ATS Medical Announces Second Quart...(2008 2007 Operating activiti...),Health

Operating activities

Net loss ($7,080) ($13,537)

Adjustments to reconcile net loss to net cash

used in operating activities:

Depreciation and amortization 2,946 1,813

Stock compensation expense 769 623

Acquired in-process research and development - 3,500

Impairment of intangibles - 755

Deferred income taxes 96 -

Non-cash interest expense 317 230

Change in value of common stock appreciation

rights and convertible senior notes derivative

liabilities (273) 241

Changes in operating assets and liabilities (1,278) 1,947

Net cash used in operating activities (4,503) (4,428)

Investing activities

Maturities of short-term investments, net

of purchases 4,183 4,224

Payments for business acquisitions (1,000) (22,000)

Business acquisition costs - (1,655)

Payments for technology licenses and other

intangibles - (23)

Purchases of furniture, machinery and equipment (886) (273)

Net cash provided by (used in) investing

activities 2,297 (19,727)

Financing activities

Advances on bank notes payable - 8,600

Repayments on notes payable (662) (2,327)

Net proceeds from sales of common stock and

warrants 3,381
'/>"/>